### 45. calls for investments in healthcare personnel to enhance their skills , and support member states in improving their working conditions , in order to attract the next generation of healthcare workers and address the lack of medical professionals and brain drain within the union; ### 45. calls for mandatory investments in health and care personnel , facilitating access to education and training , and supporting member states in improving healthcare workers working conditions and promoting gender-balance in this line of work , in order to attract the next generation of health and social care workers and address the lack of medical professionals and care professionals and brain drain within the union; believes that member states should be held accountable on their investments made in health workforces and public healthcare systems through the european semester; further believes that member states should regularly report on their investments’ impacts on availability and accessibility of health and care services for all as well as on healthcare workers mobility to better develop retention strategy of healthcare workers in europe; calls for an eu level study on the pay , conditions and factors that result into gender imbalance of health workers across europe in order to inform recommendations on this matter;


### 46. reiterates that the eu needs to take a stronger role in guiding and orienting the improvement of public health , as all member states should consider health a strategic asset for investments and not a cost to be minimised; ### 46. reiterates that the eu needs to take a stronger role in guiding and orienting the improvement of public health and social services , as all member states should consider health and social care structures a strategic asset for investments and not a cost to be minimised; calls on the eu and member states to recognize the essential role of public healthcare , to strongly invest in public healthcare to repair the damage done since the 2008 economic crisis and to exclude the public health and care sector from potential austerity measures in the future;


### 47. highlights the need to upskill , reskill and out-skill workers for healthcare careers in order to be better prepared for potential emergency and crisis situations; calls for due consideration to be given to the further training and retraining of workers involved at all stages of the value chain; ### 47. highlights the need to upskill and reskill workers for health and social care careers in order to be better prepared for potential emergency and crisis situations; calls for due consideration to be given to the further training and retraining of workers involved at all stages of their careers ; recommends that health workforce availability across europe be monitored at eu level;


### 48. underlines the importance of primary care and ‘assistance at proximity’ in building resilient health systems that facilitate the continuity of health services during health emergencies and contribute to avoiding hospital congestion and collapse by sustaining the provision of essential local services; ### 48. underlines the importance of primary care , homecare and ‘assistance at proximity’ in building resilient health and social services systems that facilitate the continuity of health services during health emergencies and contribute to avoiding hospital congestion and collapse by sustaining the provision of essential local services; notes that reinforced community-based care allows to reach those who need it the most;


### 49. calls for the eu and the member states to rethink the role of primary care , focusing on its potential to relate to families on a day-to-day basis , to improve prevention and promote a greater community capacity to respond to health threats , in close coordination with hospital care; ### 49. welcomes the european care strategy which underlines the important role of the social care sector to protect vulnerable populations; calls on the commission and member states to rethink the role of primary care , homecare and both formal and informal care , focusing on how to build a more integrated approach between the social care and health sectors; reminds once again the potential of the care sector to relate to families on a day-to-day basis , to improve prevention and promote a greater community capacity to respond to health threats , in close coordination with hospital care;


### eu financing instruments (eu4health , horizon europe , civil protection mechanism , cohesion funds , recovery fund , etc.) ### deleted


### 50. highlights the divergences in healthcare systems among member states and among regions within member states , in particular remote rural areas , the outermost regions and peripheral islands; calls for the use of cohesion policy to even out these divergences; ### deleted


### 51. notes that economic support , the government response and stringency indices differed depending on each member state’s income support , fiscal measures and restriction measures; highlights that different demographics and cultural specificities , such as the large population of older people in italy and tourism as an active business sector in southern countries , led to different pandemic socio-economic impacts; ### deleted


### 52. notes that lessons learned showed a lack of investment at eu and member state level in comprehensive , integrated surveillance systems and the management of validated , comparable and interoperable data , which led to poor planning and preparedness , although previous investments in research and development (r&d) made it possible for vaccines to be produced; ### deleted


### 53. notes that the eu reacted quickly by easing state aid rules , suspending fiscal rules , introducing the european instrument for temporary support to mitigate unemployment risks in an emergency (sure) and nextgenerationeu and investing in joint vaccine financing; points out that member states were also able to spend and borrow easily thanks to the actions of the eu monetary and political authorities; recognises that the southern countries in the eu suffered a much larger gdp shock as a result of pandemic lockdowns compared to the eu countries in the north-west and recognises that most southern countries were reliant on tourism as a principle source of economic activity; ### deleted


### preventing shortages of critical medicines and protection devices: monitoring the manufacturing capacities of the eu health industry ### preventing shortages of critical medicines ,


### 54. calls for better coordination to enable the timely stockpiling and joint procurement of medical countermeasures in line with the eu’s civil protection mechanism and the resceu stockpile; ### 54. calls for better coordination to enable the timely , strategic and ecologically friendly stockpiling and joint procurement of medical countermeasures in line with the eu’s civil protection mechanism , the resceu stockpile and the who recommendations;


### eu health strategic autonomy: strengthening research and innovation investments through public-private partnerships , supported by a globally competitive , effective and sustainable intellectual property (ip) rights protection and incentives system ### eu health strategic autonomy: strengthening research and innovation investments through public-private partnerships;


### 55. calls for the eu and the member states to reduce the eu’s dependence on third countries and to act decisively to prevent drug shortages , address supply chain vulnerabilities in the european system of sourcing medical products and active pharmaceutical ingredients from outside europe and ensure better sharing of data from the industry , earlier projections on where shortages may occur in the future and greater transparency in the production and distribution chain of medicinal products; ### 55. calls for the commission and member states to strengthen the eu strategic autonomy on health through the adoption of a coordinated industrial approach to reduce the eu’s dependence on third countries; notes that this will be particularly essential to prevent drug shortages , address supply chain vulnerabilities in the european system of sourcing medical products and active pharmaceutical ingredients from outside europe; calls on the eu and the member states to actively require transparency of production and supply chains information as well as earlier sharing of data from the industry , as this will increase the effective answers from public authorities to shortages that may occur in the future;


### 55. calls for the eu and the member states to reduce the eu’s dependence on third countries and to act decisively to prevent drug shortages , address supply chain vulnerabilities in the european system of sourcing medical products and active pharmaceutical ingredients from outside europe and ensure better sharing of data from the industry , earlier projections on where shortages may occur in the future and greater transparency in the production and distribution chain of medicinal products; ### 55. calls for the eu and the member states to reduce the eu’s dependence on third countries and to act decisively to prevent drug shortages , address supply chain vulnerabilities in the european system of sourcing medical products and active pharmaceutical ingredients from outside europe , ensure better sharing of data from the industry , earlier projections on where shortages may occur in the future and greater transparency in the production and distribution chain of medicinal products and offer incentives for reshoring pharmaceutical manufacturing in providing an enabling production environment;


### 56. underlines the importance of robust ip protection in offering incentives in medicinal research and development , and in making europe the leading place for pharmaceutical r&d ### 56. underlines the importance of ensuring that intellectual property (ip) protection includes safeguards to prevent misuse when offering financial incentives in medicinal research and development; stresses that the eu must promote pharmaceutical r&d as well as medicine availability and affordability; highlights the public importance of promoting the sharing of ip and know-how of medical countermeasures , especially during crises; calls on the commission to support global initiatives that facilitate ip sharing such as the covid-19 technology access pool (c-tap) set up by who;


### 57. stresses that stepping up research on and development of responses to pathogens with epidemic and pandemic potential prior to epidemics and pandemics is crucial; recognises that nothing was known about sars-cov-2 and the disease caused by this new virus , including nothing about its genetic sequence (even if the sequence was then shared very soon) or its other characteristics and epidemiological behaviour , such as the methods of infection and transmission and infection , transmission and mutation rates; highlights that , therefore , in the beginning , research was required before a vaccine could be developed and that affected the industry production capacity to develop and deploy vaccines; ### 57. stresses that stepping up research on and development of responses to pathogens with epidemic and pandemic potential , as well as their monitoring via the increase of sequencing capacities , prior to epidemics and pandemics is crucial; notes that despite coronaviruses long being recognized as pathogens with pandemic potential , r&d investments were lacking in developing suitable countermeasures ahead of the covid-19 pandemic due to a lack of commercial interest; underlines that the coalition of emergency preparedness in innovation (cepi) was created to address the market failure of lack of vaccines for emerging infectious diseases;


### 58. notes that high-income countries facilitated the vaccine market at the beginning of the pandemic , hosting most of the large manufacturing facilities , and that major pharmaceutical corporations enhanced the global production and supply of lifesaving medical tools by ownership of ip , technologies and data; ### deleted


### 59. highlights that the access to covid-19 tools accelerator demonstrated the power of international collaboration , speed , equity , transparency and innovation , because it enabled a rapid response and an unprecedented level of coordination and collaboration among global health agencies to address the pandemic; emphasises , at the same time , the importance of learning lessons from this initiative; ### deleted


### 142. notes that the labour market is still affected by the consequences of the pandemic and 94 % of workers were living in countries with workplace closures just over one year ago29 , moreover the war in ukraine and the food and energy crises have led to a further global economic downturn; ### deleted


### 148. acknowledges that in 2020 , 3.6 % of women’s employment was lost compared to 2.9 % of men’s employment , while the greatest losses were in the americas , followed by asia-pacific , europe and central asia , and africa; notes that in 2021 , there were still 20 million fewer women in work than before the pandemic , compared to 10 million fewer men; notes that women were overrepresented in the hardest-hit sectors , such as the hospitality and food services sector , manufacturing and the health sector; takes the view that those delivering care were at centre stage of the pandemic; notes that a large percentage of workers in care are women who are subject to unequal pay; ### 148. acknowledges that in 2020 , 3.6 % of women’s employment was lost compared to 2.9 % of men’s employment , while the greatest losses were in the americas , followed by asia-pacific , europe and central asia , and africa; notes that in 2021 , there were still 20 million fewer women in work than before the pandemic , compared to 10 million fewer men; notes that women were overrepresented in the hardest-hit sectors , such as the care , hospitality and food services sector , manufacturing and the formal healthcare sector; takes the view that those delivering care were at centre stage of the pandemic; notes that a large percentage of workers in care are women who are subject to unequal pay; whilst also performing the main part of informal and unpaid household and care work;


### 149. highlights that during lockdowns resulting from the pandemic , male violence towards women increased significantly as the restrictive measures fostered a particularly enabling environment for abusers; notes , moreover that digitalisation drove an observable rise in online abuse particularly affecting vulnerable populations; ### deleted


### 150. confirms that the restrictive measures in member states affected the mental health of teenagers and young adults; notes that there is evidence of a rise in mental health problems , anxiety , depression-related symptoms and suicidal behaviours; notes that lockdowns and the consequent lack of physical exercise also increased the prevalence of eating disorders and that all these issues were particularly manifest in vulnerable at-risk groups; ### 150. confirms that the restrictive measures in member states impacted education and employment of youth , and with that affected their mental health and social capital; notes that there is strong evidence of a rise in mental health problems , anxiety , depression-related symptoms and suicidal behaviours; notes that lockdowns and the consequent lack of physical exercise also increased the prevalence of eating disorders and that all these issues were particularly manifest in vulnerable at-risk groups;


### 151. notes that some younger students showed a decline in reading , writing and maths skills; points out that among students from low-income households this learning deficit was found to be twice that among those from higher-income households , such that the gap between the strongest and weakest students has widened; ### 151. notes with concern that many children from disadvantaged groups were unable to access online schooling during the pandemic , due to lack of or insufficient access to digital devices and lack of facilitating factors , such as access to electricity , internet , inability to use devices , or lack of parental support; acknowledges that children from ethnic minorities , such as roma and those with a migrant background and children with disabilities were disproportionately affected; highlights that some younger students showed a decline in reading , writing and maths skills; points out that among students from low-income households this learning deficit was found to be twice that among those from higher-income households , such that the gap between the strongest and weakest students has widened;


### 154. finds that the pandemic had a disastrous impact on people with disabilities; emphasises that people with disabilities faced discrimination in terms of access to healthcare and difficulty obtaining ppe; stresses that lockdowns resulted in feelings of loneliness , which exacerbated addiction and mental health issues , particularly among low-income families , women , the elderly , children , and people with disabilities , who were the most vulnerable group; notes that the needs of socially disadvantaged groups were not met at the beginning of the first lockdown; points out that social services were not considered critical infrastructure and the important role of socio-economic factors in health risks was not recognised; ### 154. finds that the pandemic had a disastrous impact on persons with disabilities; emphasises that persons with disabilities faced discrimination in terms of receiving adequate information about the pandemic , access to healthcare and difficulty obtaining ppe; notes that persons with disabilities saw access to care , education and rehabilitation services limited (lack of equal access to digital tools); notes with concern the high death tolls of persons with disabilities who were in institutions;


### 156. highlights that the pandemic and the restrictive measures have aggravated pre-existing disparities in obesity and metabolic health , with an overall rise in excess body weight , especially among women , lower educated and lower paid people , and psychiatric patients; notes that the quality of people’s diets often worsened , and physical activity declined due to the closure of sport facilities and play areas , leading to a rise in sedentary behaviour; ### deleted


### 157. notes that homeless people faced challenges in staying safe from infection , increasing their mortality risk , and shelters did not operate adequately because of smaller numbers of workers and volunteers; ### 157. notes that homeless people faced challenges in staying safe from infection , increasing their mortality risk , and shelters did not operate adequately because of smaller numbers of workers and volunteers as well as a lack of proper initial guidance and financial support to services;


### 158. notes that during the pandemic the eu moved towards new forms of digitalisation and flexible working; highlights that the appropriate use of digital tools can be an asset to employers and workers in terms of allowing greater freedom , independence and flexibility to better organise working time and working tasks , reduce time spent travelling to work , and make it easier to manage personal and family obligations , thus enabling a better work-life balance; notes that workers’ needs vary widely and therefore emphasises the importance of developing a clear framework that simultaneously promotes personal flexibility and protects workers’ rights; ### 158. notes that during the pandemic the eu moved towards new forms of digitalisation and flexible working; highlights that the appropriate use of digital tools can be an asset to employers and workers in terms of allowing greater freedom , independence and flexibility to better organise working time and working tasks , reduce time spent travelling to work , and reduce emissions;


### 159. calls on the commission and member states to take the necessary steps to make europe a truly business-friendly environment , with increased access to capital , more flexibility and less red tape for european companies so as to enable them to react quickly , continue business innovation and encourage entrepreneurship , while at the same time protecting and enforcing workers’ rights within the eu’s borders; ### 159. calls on the commission and member states to take the necessary steps to have a social europe , more resilient to react quickly to crises , continue business innovation and encourage entrepreneurship , while at the same time protecting and enforcing workers’ rights within the eu’s borders;


### 160. stresses the need to strengthen support for member states’ social policies , with due respect for the principle of subsidiarity , so that no one is left behind; to achieve equal and effective access to social protection , strengthening efforts to achieve higher levels of employment while narrowing inequalities and gender gaps in relation to pay and benefits , and further reinforcing social dialogue; ### 160. stresses the need to strengthen support for member states’ social policies and safety nets , in line with the european pillar of social rights and the employment guidelines , so that no one is left behind; to achieve equal and effective access to adequate social protection , strengthening efforts to achieve higher levels of quality employment while narrowing inequalities and gender gaps in relation to pay and benefits , and further reinforcing social dialogue with the objective to fight against precarious or undeclared work , in the care sector;


### 161. calls on the commission and member states to support , strengthen and safeguard freedom of movement (of people , goods and services) in future pandemics and minimise the burden of documentation and legislation; emphasises the need for rules and guidelines on travelling and disease detection to be harmonised between the member states to simplify procedures for smes; ### 161. calls on the commission and member states to support , strengthen and safeguard freedom of movement (of people , goods and services) in future pandemics; emphasises the need for rules and guidelines on travelling and disease detection to be harmonised between the member states;


### 163. notes that the commission recommended that member states recognise covid-19 as an occupational disease in certain sectors during a pandemic; ### 163. notes and reiterates the commission’s recommendation towards member states to recognise covid-19 as an occupational disease in certain sectors during the pandemic , and adjoining financial support or compensation for workers infected by covid-19 and families who lost members because of work exposure;


### 164. states that while eu cooperation during the pandemic suffered some teething problems , it quickly made up for lost time with several key initiatives; notes that the free movement of goods and critical health staff was made possible through the establishment of green corridors; notes that the european agency for safety and health at work (eu-osha) played an important role in providing guidelines and information to businesses about covid-19 preventive measures , while the qr-code-based covid-19 certificate demonstrated that the eu was able to create a common digital certificate to benefit administrations , companies and the public; ### 164. states that while eu cooperation during the pandemic suffered some teething problems , it quickly made up for lost time with several key initiatives; notes that the free movement of goods and critical health staff was made possible through the establishment of green corridors; notes that the european agency for safety and health at work (eu-osha) played an important role in providing guidelines and information to businesses about covid-19 preventive measures , while the eu digital covid certificate introduced an harmonised framework to facilitate free movement and travel across the eu;


### 165. recommends that lockdowns or other drastic safety measures should be taken in consultation with social partners at all the different stages of an unfolding emergency; ### 165. recommends that lockdowns or other drastic safety measures should be taken in consultation with social partners and civil society at all the different stages of an unfolding emergency;


### 166. concludes that measures to preserve sme jobs where possible through support schemes , income support , upskilling and reskilling of workers , reinforced support to the hardest-hit self-employed sectors should be further boosted; ### 166. concludes that measures to preserve sme jobs where possible through support schemes , adequate income support , upskilling and reskilling of workers , education and lifelong learning reinforced support to the hardest-hit self-employed sectors should be further boosted;


### 167. calls on the member states to take full advantage of rrf funding , which is built on the notion of ‘build back better’ , with a view to reinforcing research and innovation and kick-starting the economy through ambitious proposals and policies , focusing particularly on the green and digital transition , in order to make the eu stronger; ### 167. calls on the member states to take full advantage of rrf funding , which is built on the notion of ‘build back better’ , with a view to strengthening social investments , reinforcing research and innovation and kick-starting the economy through ambitious proposals and policies , focusing particularly on the green and digital transition , in order to make the eu more social and more resilient; further believes that reinforcing our public healthcare systems and tackling health inequalities should be the third pillar of this transition;


### 168. believes that the eu should endeavour to ensure solidarity and coordination between the member states on the economy to strengthen eu competitiveness and avoid fragmentation of the internal market; ### 168. believes that the eu should endeavour to ensure solidarity and coordination between the member states on the economy to strengthen eu competitiveness while pursuing social and climate objectives and avoid fragmentation of the internal market;


### 169. calls on the commission and member states to combat violence against women in all its forms and wherever it occurs , whether inside or outside the home; welcomes the commission’s proposal for a directive on combating violence against women and domestic violence but calls for its content to be improved to protect victims better; ### 169. calls on the commission and member states to combat gender-based violence in all its forms and wherever it occurs , whether inside or outside the home; welcomes the commission’s proposal for a directive on combating violence against women and domestic violence but calls for its content to be improved to protect all victims better; in particular those at risk of multiple discrimination;


### 170. suggests that the development of virtual or digital solutions should be promoted to allow women to reach for support more easily and safely; ### deleted


### 171. believes that cooperation between countries should be enhanced while decentralising care to better reach isolated populations; is convinced that local communities and the role of women have to be at the centre of solutions; considers that fostering innovation and digitalisation within the health service , particularly in areas where health provision is lagging is key as is relying on the expertise of civil society organisations; ### deleted


### 173. calls for the eu and member states to step up their efforts to mainstream the gender perspective in eu policy and national recovery plans; ### 173. calls for the eu and member states to mainstream the gender perspective in eu policy and national recovery plans; stresses the importance of training to provide staff with the expertise to effectively implement gender mainstreaming and gender budgeting;


### 174. calls for the eu and member states to closely monitor the use of rrf funds and their role in supporting measures for children , young people and young families; considers that investments should be made in compensatory policies , focusing on low socio-economic status individuals , programmes to prevent learning deficits , evidence-based education , adaptation of curricula , and investment in technology , school infrastructure and teachers’ professional development; is convinced that more eu funding on research is needed; ### 174. calls for the eu and member states to closely monitor the use of rrf funds and their role in supporting measures for children , young people and young families; considers that investments should be made in compensatory policies , focusing on low socio-economic status individuals and children from disadvantaged groups , programmes to prevent and tackle learning deficits , evidence-based education , adaptation of curricula , and investment in technology , school infrastructure and teachers’ professional development; is convinced that more eu funding on research is needed;


### 175. calls on the commission to gather more information about the impact of the pandemic on children’s rights and psycho-social development , the empowerment of children regarding their rights , the inclusion of emergency measures concerning children in policy and legislation; ### 175. calls on the commission to gather more information about the impact of the pandemic on children’s rights , such as right to health , in particular with view to long covid in children and psycho-social development , the empowerment of children regarding their rights , the inclusion of emergency measures , but also health consequences of pandemics concerning children in policy and legislation;


### 60. notes that the pandemic put pressure on global supply chains , including the pharmaceutical sector , resulting in disruptions and unpredictability in the supply of vaccines and other countermeasures; ### 60. notes that the pandemic put pressure on global supply chains , including the pharmaceutical sector , which is overly reliant on a limited number of countries which resulted in disruptions and unpredictability in the supply of vaccines and other countermeasures highlights the need to introduce in the eu pharmaceutical legislation robust measures for the prevention of medicine shortages;


### 61. stresses the importance of generic , biosimilar and value added medicines in preventing shortages of medicines , avoiding the consequences of disruptions in pharmaceutical supply chains during emergency situations , consistently increasing equitable access for patients and making healthcare systems sustainable in an eu in which access is still uneven; ### 61. stresses the importance of generic , biosimilar and affordable medicines in preventing shortages of medicines , avoiding the consequences of disruptions in pharmaceutical supply chains during emergency situations , consistently increasing equitable access for patients and making healthcare systems sustainable in an eu in which access is still uneven;


### 62. calls on the commission to consider new processes to promote the repurposing of medicinal products to facilitate broader off-label use of medicines , including less expensive medicines , whenever there is strong scientific evidence of efficacy and safety for patients in order to avoid shortages of medical countermeasures and the effects of disruption in pharmaceutical global supply chains; highlights , in addition , the opportunity for a new framework to support the marketing and use of drugs with new approved indications; ### 62. calls on the commission , member states and pharmaceutical companies to consider new processes to promote the repurposing of medicinal products to facilitate broader use of medicines , including less expensive medicines , whenever there is strong scientific evidence of efficacy and safety for patients in order to avoid shortages of medical countermeasures and the effects of disruption in pharmaceutical global supply chains; highlights , in addition , to support the research and development on- and use of drugs with new approved indications;


### 63. recalls the critical need for global health and for global supply chains to develop local production and distribution capacities in the eu and in developing countries , notably in terms of pharmaceutical research , development and production and always according to social standards and industry due diligence; calls on the commission to use the industrial , ip and pharmaceutical strategies to bridge the persistent gap in research and medicine production through product-development partnerships and the creation of open centres for research and production; ### 63. recalls the critical need for global health and for global supply chains to develop local production and distribution capacities in the eu and in low and middle income countries , notably in terms of pharmaceutical research , development and production and always according to social standards and industry due diligence; calls on the commission to use the industrial , ip and pharmaceutical strategies to condition public funding of research and development projects to the respect of the principle of open science , to bridge the persistent gap in research and medicine production through product-development partnerships , technology transfer and the creation of open centres for research and production;


### 64. understands that the political and economic consequences of the response to the covid-19 pandemic occurred before health systems were overwhelmed , notably by the collapse of global supply chains; ### deleted


### 66. highlights that a framework for compulsory licensing is provided for under the existing agreement on trade-related aspects of intellectual property rights , enabling governments to supply their citizens with generic versions of patented treatments either through domestic production or foreign imports; ### 66. highlights that a framework for compulsory licensing is provided for under the existing agreement on trade-related aspects of intellectual property rights , but that its practical use is hindered by regulatory data protection , trade secrets and restrictions in import and export of components and finished products produced under a compulsory license;


### 67. acknowledges that the eu is a major exporter of vaccines in the world and that it contributed to the worldwide solidarity efforts with the donation of 500 million doses of vaccines; ### 67. acknowledges that companies based in the eu are major exporters of vaccines in the world and that the eu contributed to the worldwide efforts to supply vaccines with the donation of 500 million doses , although regrettably soon to be expired which made it difficult for receivers' countries to use them in time and resulted in vaccines’ doses having to be discarded;


### 68. believes that the eu needed a common approach for vaccine procurement in order to avoid competition among member states and the undermining of the european project; believes that the exclusivity in the negotiations of vaccines and the early engagement from the member states were successful points in this process; ### 68. believes that the eu needed a common approach for vaccine procurement in order to maximise member states’ bargaining power; believes that procuring as a block in the negotiations of vaccines and the early engagement from the member states secured greater purchasing power in this process;


### 69. takes the view that joint procurement procedures could provide the eu and its member states with more flexibility according to their needs , whereas negotiations for the advanced purchase agreements were beneficial at a time when the development of vaccines was risky and production lines were prepared without knowing which vaccine would actually succeed or whether the vaccines would actually be approved; ### 69. recognises that negotiations for the advanced purchase agreements were beneficial at a time when the development of vaccines was uncertain and production lines were prepared without knowing which vaccine would actually succeed or whether the vaccines would actually be approved; takes the view that joint procurement procedures provided the eu and its member states with different options to provide treatments and vaccines to their populations; however , notes that more flexibility in review clauses will be necessary in the future to allow for member states to adjust the contracts to their needs;


### 70. stresses the importance of new joint eu voluntary public-procurement contracts by the commission and the member states , especially for , but not limited to , emergency medicines and unmet therapeutic needs , to improve their affordability and access to them at eu level; calls for such practices to be explored in areas such as rare diseases and cancer through clearly outlined milestones , objectives and commitments agreed on by all parties involved; highlights the need to ensure high levels of transparency in these initiatives and to apply lessons learned from the joint procurement of covid-19 products; stresses that joint procurement must not risk having a negative impact on supply flows by increasing the risk of shortages in the eu; ### 70. stresses the importance of new joint eu voluntary public-procurement contracts by the commission and the member states , especially for , but not limited to health emergencies; highlights the need to ensure high levels of transparency in these initiatives and to apply lessons learned from the joint procurement of covid-19 products; calls for joint procurement initiatives to diversify the number of suppliers which can help ensuring supply security;


### 71. welcomes the reference in the pharmaceutical strategy for europe to the fact that actions in the area of public procurement can foster competition and improve access to medicines; urges the commission , in the context of directive 2014/24/eu23 , to swiftly propose guidelines for the member states , notably on how to best implement the most economically advantageous tender criteria , looking beyond solely the lowest price criteria; emphasises that security of supply is an essential factor and must be used as a qualitative criterion in connection with the awarding of public pharmacy contracts and calls for tendering for the supply of medicines; emphasises the importance of diversified supplies and sustainable procurement practices for pharmaceuticals; proposes that investments in the manufacture of active ingredients and medicinal end products in the eu should also be retained as an essential criterion , as well as the number and location of production sites , the reliability of supply , the reinvestment of profits into r&d and the application of social , environmental , ethical and quality standards; ### 71. welcomes the reference in the pharmaceutical strategy for europe to the fact that actions in the area of public procurement can foster competition and improve access to medicines;


### 72. highlights the lack of transparency in the joint procurement agreements negotiated with companies , which was justified by respect for the right to confidentiality; stresses that transparency in the work of the eu institutions is of the utmost importance , especially under the conditions of the unprecedented pandemic crisis; ### 72. highlights the lack of transparency in the joint procurement agreements negotiated with companies , stresses that transparency and accountability in the work of the eu institutions is of the utmost importance , especially during crises; highlights that the european parliament resolution on eu transparency in the development , purchase and distribution of covid-19 vaccines (2021/2678(rsp); calls on the commission to publish non-redacted versions of the purchase agreements without further delay;


### 73. observes that the causes of long covid are still scientifically uncertain , as are the specifics of what it includes and its long-term impact; highlights that the eu needs a strategic approach in order to address long covid , focusing on increasing research , training and primary care awareness; ### deleted


### 73. observes that the causes of long covid are still scientifically uncertain , as are the specifics of what it includes and its long-term impact; highlights that the eu needs a strategic approach in order to address long covid , focusing on increasing research , training and primary care awareness; ### 73. observes that the disease mechanisms of long covid are still under research , as well as the specifics of what this condition entails and its long-term impact; highlights that the eu needs a strategic approach in order to address long covid , focusing on increasing targeted biomedical research and clinical trials , training and primary care awareness; recommends to foster research and development of vaccines providing sterile immunity to prevent long term consequences of infection; calls for the creation of multidisciplinary rehabilitation centres for long-term covid patients across the eu countries;


### 74. stresses that the pandemic had consequences for the health of patients with communicable diseases (cds) and non-communicable diseases (ncds) linked to delays and disruptions in diagnostics and treatments , particularly for hiv , hepatitis , cancer and rare diseases , with a massive decrease in screenings for breast and colorectal cancer; ### 74. stresses that the pandemic had severe consequences for the health of patients with communicable diseases (cds) and non-communicable diseases (ncds) linked to delays and disruptions in diagnostics and treatments , particularly for hiv , hepatitis , cancer and rare diseases , with a massive decrease in screenings for breast and colorectal cancer; notes that delayed access to care for certain diseases resulted in decreased survival chances and-or complications as well as further deterioration of quality of life for patients;


### 76. takes note that cd and ncd services were disrupted due to cancellations of elective care , the closure of screening programmes , government or public transport lockdowns which hindered access to the health facilities and lack of staff , and notes that rehabilitation was the most commonly disrupted service; ### 76. redundant - compare para 74


### 76. takes note that cd and ncd services were disrupted due to cancellations of elective care , the closure of screening programmes , government or public transport lockdowns which hindered access to the health facilities and lack of staff , and notes that rehabilitation was the most commonly disrupted service; ### 76. notes with concern that cd and ncd services were disrupted due to cancellations of elective care , the closure of screening programmes , government or public transport lockdowns which hindered access to the social and health facilities and lack of staff , and notes that rehabilitation was the most commonly disrupted service; highlights that clinicians saw 1.5 million fewer cancer patients in the first year of the pandemic and an estimated 100 million cancer screening tests were not performed as a result of the pandemic;


### 77. observes that most countries that have included ncd services in national covid-19 plans have prioritised services for the four major ncds: cardiovascular disease services , cancer services , diabetes services and chronic respiratory disease services; highlights that some countries , like spain , have recognised mental health as an area to prioritise; ### deleted


### 78. highlights the fact that scientifically recognised , integrative medicine approved by public health authorities can bring benefits to patients in relation to the parallel effects of several diseases , such as cancer , and their treatment; stresses the importance of developing a holistic , integrative and patient-centric approach and of encouraging , where appropriate , the complementary use of these therapies under the supervision of healthcare professionals; ### 78. highlights the fact that scientifically recognised , integrative medicine approved by public health authorities bring benefits to patients in relation to the parallel effects of several diseases , such as cancer , and their treatment; stresses the importance of maintaining access to integrative medicine care and to develop a patient-centric approach when defining emergency plans to react to health emergencies in order to ensure continuity of care for patients and greater quality of life;


### 79. recognises that restrictions and lockdowns led to a rise in mental health issues , particularly for youth; underlines , therefore , the importance of introducing such limiting measures as a last resort; calls for support for eu governments’ actions on mental health with a focus on youth and children , while taking into account the limitations of eu competence in this area; ### 79. recognises that restrictions and lockdowns led to a rise in isolation , loneliness and mental health issues , particularly for youth , women , the elderly and people with disabilities; underlines , therefore , the importance of introducing such limiting measures as a last resort; calls for support for eu governments’ actions on mental health with a focus on youth , children , women and persons in vulnerable situations;


### 80. regrets that routine vaccination suffered from setbacks; acknowledges the importance of carrying on and improving these activities to avoid outbreaks of other vaccine-preventable diseases; ### 80. regrets that routine vaccination suffered from setbacks; acknowledges the importance of carrying on and improving these activities to avoid outbreaks of other vaccine-preventable diseases; reiterates its urgent call for a coordinated response from eu institutions , member states and online platforms to combat mis- and disinformation;


### 81. insists that covid-19 and other recent epidemics and pandemics have made it unmistakably clear that human , animal , plant and environmental health cannot be dealt with separately , but need to be addressed in a ‘one health’ approach; highlights that their interdependencies need to be better acknowledged and require intersectional work using a multi-sectoral , transdisciplinary and integrated approach; recalls that 75 % of human infectious diseases are zoonotic and that the threat of increasing antimicrobial resistance is one of the leading causes of death worldwide; ### deleted


### 82. underline that mainstreaming one health means better able to prevent , predict , prepare for , detect and respond to global health threats at both global and eu level; recommends that the one health approach be designed and implemented through public policies , legislation and research with the engagement of multiple sectors; ### deleted


### 83. encourages the eu and member states to implement the european health union package , developing a permanent agenda for health and looking at healthcare as an investment; calls for basic health services to be strengthened , as a way of improving the general state of health of the population; ### 83. encourages the eu and member states to implement the european health union package , developing a permanent agenda for health and looking at healthcare as a cornerstone of eu action; calls for health services to be strengthened , as a way of improving the general state of health of the population;


### 85. calls for eu guidance to improved when healthcare services are temporarily stopped , decreased or diverted , identifying priority patients who should continue to be diagnosed and to receive treatment; ### 85. calls for eu guidance to be improved when healthcare services are temporarily stopped , decreased or diverted , identifying priority patients who should continue to be diagnosed and to receive treatment; with particular attention to patients who need physical examination and cannot benefit from telemedicine;


### 177. recommends that , in future pandemics , schools and other education facilities should remain open , and education policy should be part of an emergency response strategy; ### 177. recommends that , in future pandemics , schools and other education facilities should remain open when possible , flexible individual solutions should be offered , digitalisation of schools should be supported and constantly developed and a comprehensive education policy taking all aspects of impacts on children and their families into account should be part of an emergency response strategy;


### 177. recommends that , in future pandemics , schools and other education facilities should remain open , and education policy should be part of an emergency response strategy; ### 177. recommends that , in future pandemics , schools and other education facilities should remain open , and education policy should be part of an emergency response strategy; as well as childcare solutions , both collective or individual;


### 182. calls for the eu and member states to invest and develop online tools and digitally empower older people , support online healthcare services and institutions financially and to develop support measures for caregivers; ### 182. calls for the eu and member states to invest and develop inclusive online tools and digitally empower older persons and persons with disabilities , support online healthcare and social services and institutions financially and to develop support measures for caregivers;


### 183. is of the opinion that there is a need to further develop innovative solutions that emerged during the pandemic , such as new modes of working , digitalisation and access for all; calls for the re- and upskilling of older workers; ### deleted


### 184. recommends that the eu and member states invest in a health and care plan for the growing elderly population; ### 184. recommends that member states ensure the right to long-term care is integrated in their social protection systems and to invest in a health and care plan for meeting the needs of the growing elderly population in a socially-just manner;


### 185. recommends that member states should carefully evaluate the risk-benefit of the restrictions on physical activity before implementing them; considers that during a health crisis , governments should provide guidance and encourage better diets , physical activity for people with special focus on the vulnerable and disadvantaged groups , in order to increase the resilience of populations in member states in the event of a future pandemic; ### 185. recommends that member states should carefully evaluate the risk-benefit of the restrictions on physical activity before implementing them; considers that during a health crisis , governments should provide guidance and encourage better diets , physical activity for people with special focus on marginalised and disadvantaged groups , in order to increase the resilience of populations in member states in the event of a future pandemic;


### 186. calls for the eu and member states to invest in a disability-inclusive process of preparedness , to prevent the devastating impacts of future crises; ### 186. calls on member states to promote policies focusing on equality of opportunity by making the collection of equality data in the context of the pandemic a norm across the public sectors; assess how health and emergency measures have disproportionately affected minority and/or marginalised communities; recommends to adopt mitigating measures , as well as ensuring that further disadvantages are not created; co-operate with civil society in the collection and analysis of equality data;


### 186. calls for the eu and member states to invest in a disability-inclusive process of preparedness , to prevent the devastating impacts of future crises; ### 186. calls for the eu and member states to invest in a disability-inclusive process of preparedness and response to crisis , to prevent the devastating impacts of future crises;


### 187. notes that in spite of massive growth in the trade of medical products , there have been considerable inefficiencies in access to personal protection equipment; ### 187. notes that in spite of massive growth in the trade of medical products , there have been considerable inefficiencies in access to personal protection equipment; treatments , vaccines and diagnostics , deplores export controls on health goods placed in the early stages of the pandemic in eu and globally;


### 188. notes that it is the governments’ responsibility to facilitate the distribution of medical products and that the wto’s role in this regard is to implement international trade facilitation , to promote international regulatory cooperation in order to boost goods imports and to reduce export bans or restrictions which are detrimental for access to vaccines; ### 188. notes that it is the governments’ responsibility to facilitate the distribution of medical products and that the wto’s role in this regard is to facilitate international trade through international cooperation;


### 189. notes the eu’s dependency on external sources of personal protection equipment and questions the role of the wto in terms of supply chains in this regard; ### deleted


### 190. highlights that tariff and non-tariff barriers have limited access to vaccines , and considers that the wto should take action to ensure the free flow of supply chains and vaccine deliveries , notably as regards export restrictions; ### 190. highlights that multiple factors have limited global access to vaccines , and considers that the wto should take action to ensure lifting of intellectual property barriers , the free flow of supply chains and vaccine deliveries , notably as regards export restrictions;


### 191. calls for the eu to focus on open strategic autonomy supporting supply chain diversification and resilience , with an open , rules-based multilateral trading system at its core to ensure the global availability of medical products and complemented by a ‘strategic supply chain diversification fund’ to actively support our companies; encourages all countries to join the wto’s agreement on trade in pharmaceutical products and urge for its scope to be extended to all pharmaceutical and medicinal products; ### 191. calls for the eu to focus on open strategic autonomy and supporting global diversification and resilience in production and supply of medical supplies , with an open , rules-based multilateral trading system at its core to ensure the global availability of medical products;


### 192. notes that patent protection is a key incentive for companies to invest in innovation and to produce new medicines; notes , at the same time , that the exclusionary effect of patents may lead to limited market supply and reduced access to medicines and pharmaceutical products; stresses that a balance should be struck between encouraging innovation through the exclusionary effect of patents and ensuring access to medicines and protecting public health; ### 192. notes that patent protection is a key incentive for companies to invest in innovation and to produce new medicines; stresses that a balance should be struck between encouraging innovation through the exclusionary effect of patents and ensuring access to medicines and protecting public health; highlights the need to ensure that public funding for biomedical r&d includes conditions that contribute to the availability and affordability of end-products;


### 196. underlines the need to place safeguards on re-exports in order to prevent illicit trade and avoid boosting existing markets; recognises that the destination must be an eligible country but that in the event of a humanitarian emergency , an initially non-eligible country may be the destination; ### deleted


### 200. highlights the fact that covid-19 vaccines global access (covax) was key to delivering vaccines to low and middle-income countries given that their facilities and capacities were built on existing ones; notes that most of low and middle-income countries’ doses came from covax; ### deleted


### 201. recognises that there is considerable effort at the global scale to increase production capacity; welcomes the fact that the eu became a model in that matter and a large investor both in terms of push (before development) and pull (advance purchase agreements) investments , which made it possible to secure enough vaccines; ### deleted


### 202. underlines that public-private cooperation during a pandemic emergency is structurally different from cooperation under ‘normal’ circumstances , where the public side provides long-term investment , additional grants or loans and the private side delivers the product; emphasises that in a pandemic situation , where much more risk is involved , public funding plays an even bigger role in the development cycle of the product (vaccine) , in conjunction with advance purchase agreements before regulatory approval; notes that this can work only if global frameworks are well crafted and if there is close coordination between all the actors involved; ### deleted


### 203. considers that team europe has proved to be central in terms of solidarity and underlines the eu’s leadership in the global response to the pandemic; ### deleted


### 204. notes that team europe has played a key role in supporting r&d efforts in africa to address the provision of critical resources and technical support to help african countries respond effectively to the pandemic and build resilience for the future; ### deleted


### 205. notes that the covid-19 task force of the commission’s directorate-general for internal market , industry , entrepreneurship and smes (dg grow) was central to increasing the eu’s strategic autonomy and resilience in the face of the pandemic , by supporting research and innovation , strengthening supply chains , and encouraging greater cooperation and coordination between member states; ### deleted


### 206. considers that safeguarding the unity of the eu single market and the use of its economic and political leverage was made possible by the development of the external dimension of the eu’s operational autonomy , through the eu-wide export authorisation mechanism; ### deleted


### 207. considers that although the level of public funding for r&d was sufficient for the rapid development of vaccines , manufacturing capacities in the eu were scaled up too slowly to match needs; ### 207. considers that although the level of public funding for r&d was sufficient for the rapid development of vaccines , manufacturing capacities in the eu were scaled up too slowly to match needs; stresses that sharing ip and know-how is necessary to ensure large-scale production and timely global availability of medical countermeasures;


### 208. considers it essential to ensure the openness of global supply chains to eu manufacturers , by maintaining close cooperation with the eu’s international partners and counterparts and by responsibly responding to protectionist reflexes from said counterparts , such as the america first principle; ### deleted


### 209. asks for tools to be set up allowing the commission to implement reciprocal trade policies when needed (to counter the defence production act , for example) , and thereby maintain an equal balance of power and bargaining abilities; ### deleted


### 210. emphasises that the eu has taken the lead in the global response and solidarity and must continue to play this role; considers that the eu must continue to lead vaccine solidarity around the world and that vaccine solidarity is part of the eu’s one health approach; ### 210. emphasises that the eu must put in more efforts to lead vaccine solidarity around the world in future pandemics; reiterates that vaccine solidarity is part of the eu’s one health approach;


### 211. underlines that the world is likely to face new epidemics and pandemics in the future and that the eu’s one health approach entails being active in global preparedness , notably regarding the loss of biodiversity that is driving pandemics; ### 211. underlines that the world is likely to face new epidemics and pandemics , as well as other public health threats , such as cbrn threats and zoonotic diseases , in the future and that the eu’s one health approach entails being active in global preparedness , notably regarding the loss of biodiversity that is driving pandemics;


### 212. highlights that in the face of the current geopolitics of globalisation , the eu should detect high-risk dependencies and establish production capacities for related products in the eu; asks for a single market emergency instrument to be established enabling the eu , in the event of a crisis , to act directly and coercively to protect the single market; ### 212. underlines the need to ensure that the eu trade policy contributes to the eu resilience and strategic autonomy , including via the use of trade defence instruments and trade safeguards; stresses that trade restrictions in time of crisis can lead to adverse effects , including for developing and neighbouring countries; is convinced that crisis preparedness is crucial to mitigate the adverse effect of supply chain disruptions in time of crisis; welcomes in this regard the proposal of the european commission for a single market emergency instrument which aims to preserve the free movement of goods , services and persons and the availability of essential goods and services in the event of future emergencies , to the benefit of citizens and businesses across the eu;


### 213. underlines the need to shift to a more pragmatic trade policy and that targeted protectionist instruments can be appropriate tools to enhance the eu’s bargaining power , protect the eu’s fundamental interests and ultimately ensure that global supply chains are actually open to the eu; ### deleted


### 216. welcomes the fact that equitable access to vaccines has been the top priority of global foundations , including cepi and gavi , and that cepi has been putting in practice the not-for-profit / no-loss principle for vaccines intended for low- and middle-income countries; ### 216. recapitulates the fact that covid-19 vaccines global access (covax) was created with the aim of delivering vaccines to low and middle-income countries but did not live up to these expectations due to lack of effective sharing of information , competing efforts of high-income countries and accumulating delays leading to the failure to meet the needs of low- and middle- income countries; regrets that most of low and middle-income countries have significantly lower immunisation rates than high-income countries; acknowledges that the failure of covax resulted in low and middle-income countries having to make bilateral deals with manufacturers in a highly competitive market leading to unfair pricing and unfavourable liability clauses;


### 217. considers that while donation of doses is good , these donations have to be thoroughly planned to ensure they make an optimal contribution to the recipients’ vaccination strategies; ### deleted


### 88. looks forwards to the inclusion of mental health in the eu health union; ### 88. calls for increased invest in community-based mental health support and services; asks the commission and the member states to include mental health impacts in their health crisis and pandemic emergency response and preparedness work , as well as any follow up to the long-covid debates;


### 89. calls on the member states to properly finance their health systems in order to ensure their immediate and long-term resilience , and to invest in critical health infrastructure , tools , structures , processes and laboratory capacity; ### 89. calls on the member states to properly finance their health systems in order to ensure their immediate and long-term resilience , to invest in critical health infrastructure , tools , structures , processes and laboratory capacity; and in high quality , accessible and affordable care services for children and people in need of long-term care;


### 90. believes , considering that by nature pandemics are very unpredictable and with the benefit of hindsight , that lessons need to be learned on how to be better prepared for negotiations with companies in order to avoid ending up with surplus vaccines and medical countermeasures; ### 90. believes , considering that by nature pandemics are very unpredictable and with the benefit of hindsight , that lessons need to be learned from joint procurement initiatives on how to be better prepared for negotiations with companies in order to avoid ending up with delivery delays , unjustified high pricing and surplus vaccines and medical countermeasures;


### 91. urges the improvement of common and joint procurement procedures in emergency situations and a more coordinated approach , allowing for contracts to be adapted; ### 91. calls for the eu to ensure that future advance purchase agreements are fully disclosed , particularly for next generation vaccines; calls for the eu to integrate commitments with regard to non-exclusive global licensing and technology transfers and to include transparency requirements for suppliers , including full disclosure of how public funding received was used when applicable and a cost-profit analysis per product; reiterates the need for the utmost transparency in the negotiation of covid-19 vaccine contracts , including through directly involving members of the european parliament in the contractual decision-making processes; calls for the european parliament to regularly receive a comprehensive and detailed analysis of the production , imports , exports and forecasts of vaccines , including information on the country of destination of eu exports , as well as the origin of vaccine and vaccine component imports;


### 92. recommends that the eu establish adequate systems to provide manufacturers with proper at-risk funding during emergencies in order to quickly adapt and scale-up production , avoiding disruptions and shortages of medicines , medical devices and services; ### 92. recommends that the eu establish adequate systems to provide manufacturers with proper at-risk funding during emergencies in order to quickly adapt and scale-up production , avoiding disruptions and shortages of health technologies , medical products and services; such mechanisms shall be transparent and contingent to approval and revision by legislative bodies;


### 93. calls on the commission to ensure that the revision of the general pharmaceutical legislation builds on a good understanding of the root causes of medicine shortages; highlights the need for the union’s pharmaceutical industry to have a diversified supply chain and a medicine-shortage risk-mitigation plan to cope with any vulnerabilities and risks to the supply chain; ### 93. calls on the commission to ensure that the revision of the general pharmaceutical legislation builds on a good understanding of the root causes of medicine shortages; puts the focus on preventative measures such as transparency requirements of supply chains; highlights the need for the union’s pharmaceutical industry to have a diversified manufacturing base preferably located within the eea , a robust supply chain and a medicine-shortage risk-mitigation plan to cope with any vulnerabilities and risks to the supply chain; calls for the commission and member states to require pharmaceutical companies to have adequate levels of strategic safety stocks , to provide early notice of medicine shortages; and to share their risk mitigation plans as well as information regarding their manufacturing and supply chains and subsequent updates regularly;


### 94. highlights the valuable role of community pharmacies and recognises their key contribution during the pandemic in continuously providing an essential and quality service; suggests that pharmacists should play a more active role in epidemiology surveillance to contribute monitoring the insurgence of cds , and invites the member states to include them in their health , care and research programmes; calls for greater recognition of pharmacies in rural areas , which enable such areas to retain their populations and ensure the availability of medicines; ### deleted


### 95. proposes that global supply chains be opened to the eu in order to prevent tariff retaliation and that stronger provisions be promoted within contracts , especially related to supply disruptions; calls for the detection of high-risk dependencies and the establishment of production capacities of related products in the eu; ### 95. proposes to include stronger provisions related to supply disruptions within contracts; calls for the detection of high-risk dependencies and the establishment of production capacities of related products in the eu; stresses the need to facilitate non-profit production of medicines;


### 96. believes that the eu should reduce its dependence on unreliable trade partners and act decisively to prevent drug shortages; advises mapping out supply chain vulnerabilities related to the european system of sourcing medical products and active pharmaceutical ingredients from outside europe; ### 96. believes that the eu should reduce its dependence on unreliable trade partners and act decisively to prevent drug shortages; advises mapping out supply chain vulnerabilities related to the european system of sourcing medical products and active pharmaceutical ingredients from outside europe and in reshoring pharmaceutical manufacturing;


### 96. believes that the eu should reduce its dependence on unreliable trade partners and act decisively to prevent drug shortages; advises mapping out supply chain vulnerabilities related to the european system of sourcing medical products and active pharmaceutical ingredients from outside europe; ### 96. believes that the eu should reduce its dependence on trade partners and act decisively to prevent drug shortages; calls on ema to map out supply chain vulnerabilities related to the european system of sourcing medical products and active pharmaceutical ingredients from outside europe;


### 97. believes that the eu should ensure better sharing of data from the industry , earlier projections on where shortages may occur in the future and greater transparency in the production and distribution chain of medicinal products where this would promote the availability and accessibility of medicines without infringing on business sensitive information; ### 97. calls on ema to ensure better sharing of data from the industry , earlier projections on where shortages may occur in the future and greater transparency in the production and distribution chain of medicinal products;


### 98. believes that the eu should increase the share of key production on our territory to strengthen europe’s supply chain autonomy , while retaining openness to global supply chain dynamics; ### 98. believes that the eu should increase the share of medical production on our territory to strengthen europe’s supply chain autonomy , while retaining openness to global supply chain dynamics;


### 99. calls on the commission to promote dialogue with the member states and all relevant stakeholders to promote ‘made in europe’ pharmaceuticals by strengthening manufacturing and supply resilience and by assessing additional criteria for national pricing at no additional cost to patients and without prejudice to the sustainability of the health system; stresses that these criteria should include high environmental manufacturing standards , robust supply chain management and investment in innovation and research; believes that stimulating and building on an attractive european industrial ecosystem for the pharmaceutical sector is one of the key conditions for continuing to foster the relocation of production facilities back to the eu; believes further that relocations of this kind can help to make eu healthcare systems more independent from third countries and more resilient to disruptions; ### 99. calls on the commission to promote dialogue with the member states and all relevant stakeholders to promote ‘made in europe’ pharmaceuticals by strengthening manufacturing and supply resilience and by assessing additional criteria for national pricing at no additional cost to patients and without prejudice to the sustainability of the health system; stresses that these criteria should include high environmental manufacturing standards , robust supply chain management and demonstrable investment in innovation and research; believes that relocations of this kind can help to make eu healthcare systems more independent from third countries and more resilient to disruptions;


### 100. recommends the simplification and harmonisation of regulatory procedures for the approval of vaccines and medicines in order to improve the fluidity of global supply chains; ### 100. recommends the harmonisation of regulatory procedures for the approval of vaccines and medicines in order to improve the fluidity of global supply chains in ways that ensures high standards of quality , safety , and efficacy;


### 101. suggests developing networks that can be mobilised to produce a variety of technologies at short notice (such as the eu fab) and address supply chain challenges and trade barriers that impact the production process; ### 101. suggests developing networks that can be mobilised to produce a variety of technologies at short notice (such as the eu fab) and address supply chain challenges and trade barriers that impact the production process , reiterates the need to facilitate non-profit production of medicines;


### 102. encourages further investment in r&d , by increasing the resources of the eu framework programme for research and innovation and the eu4health programme , and establishing hera as a future eu agency supporting research to make vaccines available in times of crisis; ### 102. encourages further investment in r&d , by streamlining and increasing the resources of horizon europe , imi and the eu4health programme , and establishing hera as a future eu agency supporting research to make vaccines and biomedical treatments for acute and post-acute disease available in times of crisis; to address unmet health needs and by using such public investments to ensure more affordable and equally accessible end-products;


### 103. calls for more research to determine the underlying causes , frequency , and best treatment options for long covid and post-acute covid-19 syndrome , since these conditions are still not fully understood; calls therefore for a coordinated programme of surveillance systems that includes data from each member state , using consistent case definitions and methodologies , and encompassing the impact of this condition on health , employment , and the economy; ### deleted


### 103. calls for more research to determine the underlying causes , frequency , and best treatment options for long covid and post-acute covid-19 syndrome , since these conditions are still not fully understood; calls therefore for a coordinated programme of surveillance systems that includes data from each member state , using consistent case definitions and methodologies , and encompassing the impact of this condition on health , employment , and the economy; ### 103. calls for more research to determine the underlying causes , frequency , and best treatment options for long covid , other post-infectious diseases and me/cfs; calls on the european commission to establish an eu network of experts on the above-mentioned diseases with a coordinated programme of surveillance systems that includes data from each member state , using consistent case definitions and methodologies , and encompassing the impact of these condition on health , employment , and the economy; highlights in this regard that many relatively ‘mild’ viruses are known to cause severe long-term diseases decades later , whereas the precautionary principle dictates that infections should be prevented where possible; therefore reiterates its call to stimulate and finance research and development of vaccines providing sterile immunity to prevent long term consequences of viral infections;


### 104. calls on the commission to periodically evaluate and review the incentive system , increase price transparency , and highlight the factors limiting affordability and patient access to medicinal products; ### 104. calls on the commission to periodically evaluate and review the performance of incentive system , ensure net price transparency , and highlight the factors limiting affordability of health technologies and the economic sustainability of public health systems;


### 105. encourages responsible ways to enhance transparency regarding public vaccine funding and procurement , the real costs of r&d , and access to clinical trials results and related data through the clinical trial information system; ### 105. encourages responsible ways to enhance transparency regarding public funding and procurement , the real costs of r&d , and access to clinical trials results and related data through the clinical trial information system;


### 106. urges the commission , member states and manufacturers to communicate the potential side effects of vaccines better and to do so in a consistent and coordinated way so as to avoid vaccine hesitancy and misinformation; ### 106. urges the commission , member states and manufacturers to be more transparent , and communicate consistently and comprehensively about adverse effects of vaccines , not only , because this helps to avoid vaccine hesitancy and misinformation in an enlightened society , but also with view to prevent harm and from individuals , avoid stigma , to mitigate adverse effects and as precondition to provide full support for cure , compensation and improving vaccines , as this is what it takes to leave no one behind;


### 106. urges the commission , member states and manufacturers to communicate the potential side effects of vaccines better and to do so in a consistent and coordinated way so as to avoid vaccine hesitancy and misinformation; ### 106. urges the commission , member states and manufacturers to communicate as per existing regulation the potential side effects of vaccines better and to do so in a consistent and coordinated way so as to avoid vaccine hesitancy and dis- and misinformation; stress the importance of pharmacovigilance , mitigation measures to prevent adverse reactions , liability , and swift compensation in case of injury; recommends further to strengthen the european pharmacovigilance system;


### 107. calls for hera to be made an autonomous agency , with a strong and well-defined mandate from council and parliament (including a proper industrial role and mandate) , and a budget to fulfil its mandate and increase resources; calls for hera to have a role in safeguarding the public interest; ### 107. calls for hera to be made an autonomous agency , with a strong and well-defined mandate from council and parliament (including a proper industrial role and mandate) , and a budget to fulfil such mandate and increase resources; calls for hera to have a role in safeguarding the public interest; including through access conditions and legal options to mandate technology transfer and knowledge sharing;


### 108. welcomes the commission healthier together – eu ncd initiative to support eu countries in identifying and implementing effective policies and actions to reduce the burden of major ncds and improve citizens’ health and well-being; ### deleted


### 109. is concerned that during the pandemic the executive branch had the upper hand in emergency decision-making , which undermined the role of the european parliament; calls on the commission and the council to refrain from using article 122 tfeu , and to increase parliamentary control and codecision for various instruments so as to bolster the legitimacy of emergency response actions; ### deleted


### 110. believes that there are transparency issues concerning the design and implementation of the resilience and recovery fund facility , including a lack of clear obligations to publish data on details of the spending of the funds received; is of the opinion that without common standards on data sharing , there is a significant risk of corruption and recommends that member states should put more effort into sharing data on their national recovery plans; ### deleted


### introduction and overview ### deleted


### 1. acknowledges that the spread of the covid-19 has cost the lives of millions of people in europe and the world and has caused irreparable damage , and that the eu , as well as the rest of the world , was not ready to cope with this unprecedented health crisis and its shock waves , which have affected societies and economies worldwide; ### 1. acknowledges that the spread of the covid-19 has cost the lives of millions of people in europe and the world and has caused irreparable damage , and that the eu was not ready to cope with this unprecedented health crisis and its shock waves , which have affected societies and economies worldwide;


### 2. considers that , despite shortcomings and gaps in prevention , preparedness and response , the eu developed a common response to the pandemic and took actions to ensure the swift development and fair distribution of vaccines on the european continent and globally; ### 2. considers that , despite shortcomings and gaps in prevention , preparedness and initial response , the eu developed a common response to the pandemic and took actions to ensure the swift development and fair distribution of vaccines on the european continent;


### 4. highlights that the pandemic exacerbated existing structural issues in the health sector , in particular workforce shortages; ### 4. notes that the covid-19 pandemic should be seen as an opportunity to speed up transformations on the path to digital and green transitions , and serves as a stark reminder to prioritise the resilience and quality of our public healthcare systems;


### 5. affirms the importance of preparedness and resilience in the face of crises , particularly in terms of healthcare systems and supplies , in increasing strategic autonomy in key areas , such as vaccine production and distribution; ### 5. highlights that the pandemic exacerbated existing structural issues in the public health sector , in particular workforce shortages; caused by years of austerity measures and health care privatisation and a societal under appreciation of health care workers reflected in their working conditions and remuneration;


### 7. takes into account the impact of the crisis on the economy and underscores the need for a coordinated response to support businesses and self-employed people; ### 7. notes with regret that the covid-19 pandemic has disproportionately affected the mental well-being of those facing financial uncertainty , with particular negative consequences for women as well as of vulnerable populations , including ethnic minorities , the lgbti+ community , the elderly , persons with disabilities and young people;


### 8. emphasises that the economy supports our welfare state , personal freedom and a good future; calls for the eu to strengthen its economic performance in hard times by coupling economic and social measures; ### deleted


### 9. highlights that the pandemic has increased inequalities between countries and within countries , that life expectancy in europe has dropped for the first time in 50 years and that the future of the universal coverage and social welfare model has been jeopardised; ### 9. acknowledges the failure of global health governance during covid-19 , resulting in increased inequalities between countries and within countries , and global inequities in production , supply and access to live-saving medical products and health technologies;


### 11. emphasises the importance of learning lessons and being better prepared for future crises and stresses that a high level of human health protection must be ensured in the definition and implementation of all union policies and activities; stresses that we are still learning about the effects of covid on health and health systems , in particular the impact of so-called long covid effects; ### deleted


### 11. emphasises the importance of learning lessons and being better prepared for future crises and stresses that a high level of human health protection must be ensured in the definition and implementation of all union policies and activities; stresses that we are still learning about the effects of covid on health and health systems , in particular the impact of so-called long covid effects; ### 11. emphasises the importance of learning lessons and being better prepared for future crises and stresses that a high level of human health protection must be ensured in the design , definition and implementation of all union policies , legislation and activities; stresses that we are still learning about the effects of covid on health and health systems , in particular regarding long covid;


### 12. stresses that europe can only pull through future pandemics if the european family stands together in solidarity and responsibility , and fully utilises its capabilities to coordinate better and deliver the needed added-value to eu governments and their citizens; ### 12. stresses that europe can only pull through future pandemics if the european family stands together in solidarity and responsibility , and fully utilises its capabilities to coordinate better and deliver the needed added-value to eu governments and their citizens; underlines in this regard the need for better eu practices concerning transparency and democratic accountability regarding crises countermeasures , to underpin citizens' support and trust;


### 13. underlines the importance of science-based decision-making and consistent communication with citizens from all the stakeholders involved , including eu and member state public institutions , the scientific community , the private sector and civil society organisations; ### 13. underlines the importance of science-based decision-making and consistent communication with citizens from all the stakeholders involved , including eu institutions and member state public offices , the scientific community , the private sector and civil society organisations;


### 14. calls for the eu to continue on the path towards establishing a european health union that brings true added-value to the health governance of the member states and operates in fields that cannot be covered by the member states alone; ### 14. calls for the eu to continue the path towards establishing a european health union that brings a solid mechanism for joint procurement with clear guidelines on transparency and democratic accountability , a robust pandemic preparedness planning and a more integrated surveillance system;


### 15. recognises that all the actions taken during the pandemic were meant to safeguard the right to health and life , but that some actions nevertheless implied the existence of limitations on other fundamental rights; highlights that , because the crisis was unprecedented , governments had to take swift action with very little preparation and a lack of internal expertise; ### 15. recognises that some countermeasures required limitations on fundamental rights such as freedom of assembly , right to education , freedom of mobility and movement , as well as the right to life; highlights that these rights are constitutionally protected rights at all times , even under conditions of emergency; and that in future health emergencies measures infringing on fundamental rights should only be used as a last resort and be tested on the principles of proportionality , and be accompanied by judicial oversight and democratic dialogue;


### 6. recalls that personalised services to be provided to the workers and self-employed persons consist of the following actions: information , job-search assistance , occupational guidance and outplacement assistance , trainings , retraining and vocational training , and support towards and contribution to business creation , as well as incentives and allowances; ### 6. recalls that personalised services to be provided to the workers and self-employed persons consist of the following actions: information , job-search assistance , occupational guidance and outplacement assistance , trainings , retraining and vocational training , and support towards and contribution to business creation , as well as incentives and allowances; welcomes that particular attention will be paid to vulnerable people in a situation of psychological distress , indebtedness , or recognised disability through professionals specialised in assisting these groups;


### 8. welcomes the fact that the co-ordinated package of personalised services was drawn up by belgium in consultation with targeted beneficiaries’ representatives; ### 8. welcomes the fact that the co-ordinated package of personalised services was drawn up by belgium in consultation with targeted beneficiaries’ representatives , including trade unions (fgtb1a and csc1b) and social counsellors who accompanied the workers , to better understand workers' retraining needs after their dismissal;


### 10. reiterates that assistance from the egf must not replace actions which are the responsibility of companies , by virtue of national law or collective agreements; ### 10. reiterates that assistance from the egf must not replace actions which are the responsibility of companies , by virtue of national law or collective agreements , or any allowances or rights of the displaced workers , to ensure full additionality of the allocation;


### g. whereas the regional government of galicia , in compliance with article 7(4) of regulation (eu) 2021/691 , involved social partners in the preparation of the egf application and drew up the co-ordinated package of personalised services in cooperation with them; whereas social partners will also be involved in the implementation of the services; ### g. whereas the regional government of galicia , in compliance with article 7(4) of regulation (eu) 2021/691 , involved social partners in the preparation of the egf application and drew up the co-ordinated package of personalised services in cooperation with them; whereas galician and spanish social partners will also be involved in the implementation of the services;


### 4. highlights that alu ibérica was among the 0 ,1 % of businesses in galicia with more than 250 employees; underlines the significant impact of the displacement on the local labour market and economy of a coruña , a city which has been marked by a high unemployment rate well exceeding the union average (9 ,5 % in q3/2022); takes note of the estimation of spanish authorities that the liquidation of alu ibéria will trigger the loss of 312 jobs in ancillary enterprises , which would bring the total number of job losses to 615 , equalling 8 ,2 % of the manufacturing jobs in a coruña; ### 4. highlights that alu ibérica was among the 0 ,1 % of businesses in galicia with more than 250 employees; underlines the significant impact of the displacement on the local labour market and economy of a coruña , a city which has been marked by a high unemployment rate well exceeding the union average (9 ,5 % in q3/2022); takes note of the estimation of spanish authorities that the liquidation of alu ibéria will trigger the loss of 312 jobs in ancillary enterprises , which would bring the total number of job losses to 615 , equalling 8 ,2 % of the manufacturing jobs in a coruña; points out the large mobilisations that the decision caused in the city of a coruña; stresses the loss of jobs and livelihood in galicia;


### 11. reiterates that assistance from the egf must not replace actions which are the responsibility of companies , by virtue of national law or collective agreements; ### 11. reiterates that assistance from the egf must not replace actions which are the responsibility of companies , by virtue of national law or collective agreements , or any allowances or rights of the displaced workers , to ensure full additionality of the allocation;


### 1. underlines the exceptionally uncertain eu economic outlook resulting from the lasting impact of the covid-19 pandemic and the consequences of the war against ukraine; ### 1. underlines the exceptionally uncertain eu economic outlook resulting from the lasting impact of the covid-19 pandemic and the consequences of the war against ukraine and the energy and cost of living crisis;


### 1. is concerned that the eu is one of the most exposed advanced economies to downward risks , given its geographical proximity to ukraine and heavy reliance on gas imports from russia; notes that the impact of high energy prices and inflation leads to the erosion of household purchasing power; highlights that a reduction in aggregate demand , combined with less favourable financing conditions , could lead to a sharp decline in investment and therefore in economic growth; ### 1. is concerned that the eu is one of the most exposed advanced economies to downward risks , given its geographical proximity to ukraine and heavy reliance on gas imports from russia; notes that the impact of high energy prices and inflation leads to the erosion of household purchasing power; highlights that a reduction in aggregate demand , combined with less favourable financing conditions , could lead to a sharp decline in investment and therefore in economic growth; worries that investments in renewables and energy efficiency could also suffer , though these are precisely the investments required to reduce reliance on imported fossil fuels and limit inflation driven by energy prices;


### 2. welcomes the robustness of the labour market; highlights the stabilising effect of national short-time work schemes supported by the european instrument for temporary support to mitigate unemployment risks in an emergency (sure); welcomes the fact that the recovery and resilience facility is mitigating those consequences and contributing to the union’s competitive sustainability; stresses that its successful implementation requires the completion of milestones and targets , in particular compliance with the rule of law and the general regime of conditionality , to be monitored transparently and thoroughly; welcomes the commission’s proposal to include a repowereu chapter in the national recovery and resilience plans; insists that the financing of repowereu must not divert resources away from other eu priorities; ### 2. welcomes the robustness of the labour market; highlights the stabilising effect of national short-time work schemes supported by the european instrument for temporary support to mitigate unemployment risks in an emergency (sure); welcomes the fact that the recovery and resilience facility is mitigating those consequences and contributing to the union’s competitive sustainability the just transition transition and digitization; stresses the importance that reforms and investments under the recovery and resilience plans meet the climate targets of the regulation and are in full respect of the “do no significant harm” principle and contribute to reaching the 2030 national climate and energy and to achieve climate neutrality by 2050 the latest; stresses that its successful implementation requires the completion of milestones and targets and the no regression in the achievements , in particular compliance with the rule of law and the general regime of conditionality , to be monitored transparently and thoroughly; welcomes the commission’s proposal to include a repowereu chapter in the national recovery and resilience plans; insists that the financing of repowereu must not divert resources away from other eu priorities. calls for a swift implementation of repowereu amendment of the rrf regulation and in particular to speed up investments in reneweables and energy efficiency to decrease dependence on fossil fuels as fast as possible;


### 3. stresses that the union budget primarily supports strategic , targeted and growth-enhancing investment and entails a lower risk of inflationary pressure compared to untargeted and extensive national fiscal stimulus; calls on the commission and the member states , in the revision of the eu economic governance framework , to treat gross national income-based contributions to the union budget in the same way as the national investment commitment; ### 3. stresses that the union budget primarily supports strategic , targeted and growth-enhancing investment and entails a lower risk of inflationary pressure compared to untargeted and extensive national fiscal stimulus; calls for using amortisation as the accounting method for green and social investments and national co-financing of cohesion funds compliant with paris agreement spreading the cost of net public investment over the life-cycle of an investment and thus allowing for speeding up of much needed investments; calls for the country specific debt adjustment paths should be based on key economic variables such as interest rate/growth differentials , initial debt level , composition of public debt stock;


### 4. is concerned at the economic impact of the aforementioned crises on the union and on national budgets; stresses that crisis response has led member states to adopt extensive economic measures; highlights the long-term impact of these measures on economic sustainability , but considers that it should be possible to return to a state of economic discipline in the long run; is also concerned at the union’s increasing debt repayment obligations if not appropriately handled; stresses that union borrowing should not increase further as long as there are no new own resources to cater for debt repayment. ### 4. is concerned about at the economic impact of the aforementioned crises on the union budget and on national budgets; stresses that crisis response has led member states to adopt extensive economic measures; highlights the long-term impact of these measures on economic sustainability; agrees with the commission’s orientations as regard the simplification of the framework , differences in member states’ fiscal paths , the use of a more comprehensive debt sustainability analysis and the general escape clauses; suggests the european semester should mirror the medium-term nature of the future economic policy coordination framework; is also concerned about the potential impact of the union’s increasing debt repayment obligations if not appropriately handled; stresses that new own resources to cater for debt repayment need to be implemented in urgency , in order to safeguard the integrity of the eu’s budget and policies as well as its financial capacity.